Publication | Open Access
Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
58
Citations
45
References
2018
Year
Our data reveal that DEC is active in MLL-positive BCP-ALL and warrant clinical evaluation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1